Geneos Wealth Management’s Uranium Royalty Corp UROY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-19,797
Closed -$43.4K 3170
2024
Q4
$43.4K Buy
+19,797
New +$50.9K ﹤0.01% 1372
2022
Q3
Sell
-4,500
Closed -$10K 2572
2022
Q2
$10K Hold
4,500
﹤0.01% 1964
2022
Q1
$17K Buy
+4,500
New +$17.1K ﹤0.01% 1888

Other funds holding UROY

Geneos Wealth Management's UROY Position: Q1 2025 in Review

Geneos Wealth Management sold out of Uranium Royalty Corp (UROY) in Q1 2025, closing a stake of 19,797 shares — an estimated $43.4K sold.

Geneos Wealth Management first reported a position in UROY in Q1 2022 and held it in 3 quarters. The position peaked at $43.4K in Q4 2024. 68 funds tracked by Wall St. Rank hold UROY as of Q1 2025.

  • Geneos Wealth Management reported no remaining Uranium Royalty Corp position as of Q1 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 19,797 Uranium Royalty Corp shares in Q1 2025, an estimated $43.4K.
  • Geneos Wealth Management first reported a position in Uranium Royalty Corp in Q1 2022 and held it in 3 quarters.
  • Geneos Wealth Management's Uranium Royalty Corp position peaked at $43.4K in Q4 2024.
  • 68 funds tracked by Wall St. Rank held Uranium Royalty Corp as of Q1 2025.

Based on Geneos Wealth Management's 13F filing for Q1 2025, filed 8 May 2025.